Pdt Partners, LLC Crispr Therapeutics Ag Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pdt Partners, LLC holds 17,406 shares of CRSP stock, worth $940,098. This represents 0.12% of its overall portfolio holdings.

Number of Shares

17,406

Holding current value

$940,098

% of portfolio

0.12%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $1.06 Million - $1.55 Million	17,406 New	17,406 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $158,523 - $265,635	4,045 Added 17.65%	26,965 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $233,279 - $319,872	-3,818 Reduced 14.28%	22,920 $1.5 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $788,471 - $1.35 Million	18,239 Added 214.6%	26,738 $1.63 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $452,061 - $673,460	8,499 New	8,499 $533,000

Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $554,131 - $879,858	-7,906 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $871,241 - $1.24 Million	7,906 New	7,906 $885,000
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $586,816 - $1.11 Million	-5,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $422,251 - $918,119	5,300 New	5,300 $811,000
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $252,377 - $323,557	-3,215 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $123,777 - $244,500	3,215 New	3,215 $236,000

Others Institutions Holding CRSP

# of Institutions

549

Shares Held

56.3M

Call Options Held

2.91M

Put Options Held

2.47M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.16M
Shares

$441 Million
3.97% of portfolio
Capital International Investors Los Angeles, CA

7.84M
Shares

$423 Million
0.11% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

3.27M
Shares

$177 Million
0.16% of portfolio
Nikko Asset Management Americas, Inc.

3.27M
Shares

$177 Million
2.23% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

2.7M
Shares

$146 Million
0.11% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.21B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account